EMD Serono to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 2025

businesswire

EMD Serono to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 2025 – NEWSnet – News… as it used to be

More Press Releases

May 2, 2026

American Piano Awards Names Five Finalists for the 2027 Jazz Competition

May 2, 2026

Global Familial Hypercholesterolemia Treatment Market Led by North America as Amgen and Novartis Expand Therapies

May 2, 2026

Inside the Arvix BioMatrix™ Modular System: Base, Core, and Prime Components

May 2, 2026

EMD Serono to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 2025

American Piano Awards Names Five Finalists for the 2027 Jazz Competition

Global Familial Hypercholesterolemia Treatment Market Led by North America as Amgen and Novartis Expand Therapies

Inside the Arvix BioMatrix™ Modular System: Base, Core, and Prime Components

Matlin Injury Law Expands to Aurora, Bringing Proven Legal Representation to a Fast-Growing Colorado Community